Thompson loop: opportunities for antitubercular drug design by targeting the weak spot in demethylmenaquinone methyltransferase protein

Drug-resistant Tuberculosis (TB) has remained the top global health challenge, with a yearly estimation of 10 million infections and 1.5 million deaths in humans. Demethylmenaquinone methyltransferase (menG) catalyzes demethylmenaquinone conversion to menaquinone (MK) that is implicated in the TB pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Adewumi, Adeniyi T., Soremekun, Opeyemi S., Ajadi, Mary B., Soliman, Mahmoud E. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2020
Materias:
Chemistry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054810/
https://www.ncbi.nlm.nih.gov/pubmed/35520325
http://dx.doi.org/10.1039/d0ra03206a

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054810/
https://www.ncbi.nlm.nih.gov/pubmed/35520325
http://dx.doi.org/10.1039/d0ra03206a

Ejemplares similares